AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Hepatitis vaccine approved for sale in Argentina.
2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Corixa Corporation (CRXA) announced the Argentinean approval of Supervax, Berna Biotech's prophylactic vaccine containing Corixa's synthetic RC-529 adjuvant, for the prevention of Hepatitis B infection.
Developed by Berna Biotech, the vaccine combines Berna Biotech's Hansenula polymorpha-based recombinant Hepatitis B antigen with Corixa's RC-529 adjuvant. An adjuvant is a formulated compound or additive that, when combined with a vaccine, boosts the body's immune response to the antigen(s).
Clinical results for Supervax showed seroprotection of more than 95% of the individuals vaccinated with Supervax containing Corixa's RC-529 adjuvant after only two vaccinations, 1 month apart. Berna Biotech expects to launch Supervax in Argentina next year.
"We are pleased to announce continued product commercialization progress with the approval of Supervax containing our RC-529 adjuvant," said Steven Gillis, PhD, chairman and chief executive officer at Corixa.
"This milestone - soon after the filing for approval of GlaxoSmithKline's Fendrix containing Corixa's MPL adjuvant - is further evidence of our strong commitment to aggressively move more products through clinical testing and on to product approval. The strength of our adjuvant technology and its potential contribution to Corixa's future product sales and royalty income is a distinguishing characteristic of our vaccine development efforts," Gillis ...
- Corixa Announces First Approval of an Infectious Disease Vaccine Containing the...
- Press release article from: Business Wire September 8, 2003 700+ words
...Sept. 8, 2003 Corixa Corporation (Nasdaq...approval of SUPERVAX, Berna Biotech's prophylactic vaccine containing Corixa's synthetic RC...vaccine combines Berna Biotech's Hansenula polymorpha...B antigen with Corixa's RC-529 adjuvant...
- BERNA BIOTECH PAYING EUR279M IN CASH, SHARES FOR RHEIN BIOTECH.(Brief...
- Magazine article from: BIOWORLD Today Sheridan, Cormac May 24, 2002 700+ words
Switzerland's Berna Biotech Ltd. is acquiring Rhein Biotech...shareholders will be offered 1.42 Berna Biotech shares plus EUR33.75 in cash...proposed 1:25 share split of Berna Biotech's stock is approved at its annual...
- Berna Biotech Paying EUR279M In Cash, Shares For Rhein Biotech.
- Magazine article from: BIOWORLD Today November 4, 2009 700+ words
...International Correspondent Switzerland's Berna Biotech Ltd. is acquiring Rhein Biotech NV...shareholders will be offered 1.42 Berna Biotech shares plus EUR33.75 in cash. Based...assuming a proposed 1:25 share split of Berna Biotech's stock is approved at its annual...
- Crucell Acquiring Berna Biotech In US$449M All-Share Takeover.
- Magazine article from: BIOWORLD Today Sheridan, Cormac December 2, 2005 700+ words
...agreed to an all-share takeover of Berna Biotech AG in a deal valued at CHF591 million...million). The transaction values Berna Biotech's stock at CHF15.72 (US$11...its three-month trading average. Berna Biotech shareholders will be offered 0.447...
- Berna Biotech slapped with 11-item 483 for media fills: Berna Biotech, Berne,...
- Newspaper article from: Inspection Monitor May 1, 2008 700+ words
Berna Biotech, Berne, Switzerland, received an...the audit. The report stated that Berna Biotech is a vaccine manufacturer. Only the...performed or information communicated to Berna Biotech. "The only information related to...
- Berna Biotech cited for faulty media fill procedures.(Human drugs)
- Newspaper article from: Validation Times Pickett, Joseph May 1, 2008 700+ words
Berna Biotech, Berne, Switzerland, was hit with...the audit. The report stated that Berna Biotech is a vaccine manufacturer. Only the...specifications in the agreement between Berna Biotech and an undisclosed firm related to...
- Dynavax Technologies and Berna Biotech Announce Collaboration.
- Press release article from: PR Newswire November 3, 2003 700+ words
...Dynavax Technologies Corporation and Berna Biotech Ltd. today announced execution of...details were disclosed. About Berna Berna Biotech Ltd. (Swiss Exchange: BBIN) develops...subsidiaries in Europe and Korea, Berna Biotech employs approximately 900 people...
- Berna Biotech vaccine sales rise 44%.
- Newspaper article from: Pharma Marketletter February 3, 2003 700+ words
Although Switzerland's Berna Biotech reported a 33% slump in gross revenues for 2002 at 202.8 billion Swiss francs ($149.9 million), which includes the business...
Source: HighBeam Research, Hepatitis vaccine approved for sale in Argentina.